Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 15301 - 15325 of 16010 in total
Investigational
ST101 is a cell-penetrating peptide that disrupts the protein-protein interactions driving ATF5-regulated gene transcription.
Investigational
GVAX is a granulocyte-macrophage colony-stimulating factor (GM-CSF) gene-transfected tumor cell vaccine.
Investigational
Investigational
CNDO-109 are CNDO-109-activated allogeneic natural killer cells.
Investigational
Investigational
Investigational
Investigational
Investigational
Investigational
Investigational
Investigational
Investigational
Investigational
Investigational
Maveropepimut-S is a T cell activating immunotherapy.
Investigational
Investigational
Investigational
Investigational
Investigational
Obecabtagene autoleucel is an investigational autologous CD19 CAR T cell therapy.
Investigational
Gavocabtagene autoleucel is a novel cell therapy consisting of autologous genetically engineered T cells expressing a single-domain antibody that recognizes human Mesothelin, fused to the CD3-epsilon subunit which, upon expression, is incorporated into the endogenous T cell receptor (TCR) complex.
Investigational
Investigational
Investigational
Displaying drugs 15301 - 15325 of 16010 in total